Current role
Daniel Tardiff
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Daniel Tardiff
Camp4 Therapeutics Corp reported in an 8-K filed September 10, 2025 that Daniel Tardiff was appointed Chief Scientific Officer, effective October 1, 2025.
“the Company has elevated Daniel Tardiff, Ph.D., the Company's SVP, Head of Discovery, to its Chief Scientific Officer, effective October 1, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Camp4 Therapeutics Corp (CAMP)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Camp4 Therapeutics Corp
Other people whose current roles at this company are on record from its filings.
- Josh Mandel-Brehm CEO, Board Member
- Doug Williams Chairman
- Kelly Gold CFO
- Amir Nashat Board Member
- Andrew J. Schwab Board Member
- Douglas Williams Board Member
- Douglas Williams, PhD Board Member
- Michael MacLean Board Member
- Murray Stewart Board Member
- Murray Stewart, DM FRCP Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.